Skip to content

Clinical trials

Active, not recruiting Triple Negative Breast Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Active, not recruiting Country / region: United Kingdom Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20183
20192
20202
20212
20224
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
BicycleTx Limited2
Gilead Sciences2
Alterome Therapeutics, Inc.1
Bayer1
BioNTech SE1
Cancer Research UK1
Exelixis1
GlaxoSmithKline1
Institute of Cancer Research, United Kingdom1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms17
Breast Neoplasms7
Ovarian Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Stomach Neoplasms4
Endometrial Neoplasms3
Urinary Bladder Neoplasms3
Uterine Cervical Neoplasms3
Carcinoma, Hepatocellular2
Head and Neck Neoplasms2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.